The federal government has recovered $40 million of its investment in the now-defunct Quebec-based vaccine developer Medicago as part of a deal with the parent company, the innovation minister announced Thursday.
As more details emerge about the long-term effects of COVID-19, experts say vaccination is likely to have protective benefits against long COVID, also known as post-acute sequelae SARS-CoV-2 infection. But an important question that has yet to be answered is exactly how much protection it offers.
Moderna's COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech's shot, the U.S. Centers for Disease Control and Prevention said on Tuesday, citing recent data.
Infants born to those who tested positive for COVID-19 during pregnancy may have neurodevelopmental issues after birth, according to preliminary findings from two separate studies out of the U.S. and Spain.